NBOMe-2C-D

25D-NBOMe

Legal status
Legal status	UK: Class A Illegal in China and Sweden
Identifiers
IUPAC name 2-(2,5-dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine
CAS Number	1354632-02-2
PubChem CID	118536027
ChemSpider	48059920 Y
UNII	7RET11HE13
Chemical and physical data
Formula	C19H25NO3
Molar mass	315.41 g·mol−1
3D model (JSmol)	Interactive image
SMILES COC1=C(C=C(C(=C1)C)OC)CCNCC2=C(C=CC=C2)OC
InChI InChI=1S/C19H25NO3/c1-14-11-19(23-4)15(12-18(14)22-3)9-10-20-13-16-7-5-6-8-17(16)21-2/h5-8,11-12,20H,9-10,13H2,1-4H3 Y Key:UTVHBNXCFSATDB-UHFFFAOYSA-N Y

25D-NBOMe (or NBOMe-2C-D) is a derivative of the phenethylamine derived hallucinogen 2C-D. It acts in a similar manner to related compounds such as 25I-NBOMe, which is a potent agonist at the 5HT_2A receptor. 25D-NBOMe has been sold as a street drug since 2010 and produces similar effects in humans to related compounds such as 25I-NBOMe and 25C-NBOMe. It was banned as a Temporary Class Drug in the UK on 10 June 2013 after concerns about its recreational use.

As of October 2015 25D-NBOMe is a controlled substance in China.

Sveriges riksdag added 25D-NBOMe to schedule I ("substances, plant materials and fungi which normally do not have medical use") as narcotics in Sweden as of Aug 1, 2013, published by Medical Products Agency in their regulation LVFS 2013:15 listed as 25D-NBOMe 2-(2,5-dimetoxi-4-metylfenyl)-N-(2-metoxibensyl)etanamin.

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.

Unregulated at a federal and state level, though arguably may contravene the Federal Analog Act under certain circumstances given its structural and functional similarity to controlled substance 2C-D.